Standout Papers
- Phase III, randomised trial of avelumab versus physician’s choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300 (2018)
- Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial (2024)
Immediate Impact
1 from Science/Nature 62 standout
Citing Papers
Alcohol-associated liver disease
2024 Standout
Redox-responsive polymer micelles co-encapsulating immune checkpoint inhibitors and chemotherapeutic agents for glioblastoma therapy
2024 Standout
Works of Ludovic Evesque being referenced
Phase III, randomised trial of avelumab versus physician’s choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300
2018 Standout
Effect of Detoxification on Liver Stiffness Assessed by Fibroscan® in Alcoholic Patients
2010
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Ludovic Evesque | 612 | 426 | 419 | 54 | 999 | |
| John E. Mullinax | 647 | 386 | 379 | 69 | 1.2k | |
| Jacob R. Izbicki | 567 | 352 | 388 | 45 | 1.3k | |
| Yasuharu Kaizaki | 415 | 462 | 543 | 59 | 1.1k | |
| Janet E. Murphy | 997 | 446 | 447 | 57 | 1.3k | |
| M. Priyanthi Kumarasinghe | 478 | 389 | 515 | 79 | 1.2k | |
| Anne Jouret‐Mourin | 420 | 329 | 463 | 36 | 1.2k | |
| Kanwal Raghav | 554 | 341 | 357 | 51 | 1.1k | |
| Lakshmi Rajdev | 585 | 298 | 291 | 64 | 1.0k | |
| Susanne van Eeden | 1002 | 564 | 406 | 44 | 1.3k | |
| D Marrano | 514 | 178 | 451 | 57 | 1.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...